Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Sodium Iodide I 131
×
Overview
What is Sodium Iodide I 131 Diagnostic?
What does Sodium Iodide I 131 Diagnostic look like?
What are the available doses of Sodium Iodide I 131 Diagnostic?
Capsules: 3.70 MBq (100 microCi) at the time of calibration
What should I talk to my health care provider before I take Sodium Iodide I 131 Diagnostic?
Enter section text here
How should I use Sodium Iodide I 131 Diagnostic?
Sodium Iodide I 131 Capsules Diagnostic is indicated for use in adults for:
What interacts with Sodium Iodide I 131 Diagnostic?
Sorry No Records found
What are the warnings of Sodium Iodide I 131 Diagnostic?
Sorry No Records found
What are the precautions of Sodium Iodide I 131 Diagnostic?
Sorry No Records found
What are the side effects of Sodium Iodide I 131 Diagnostic?
Sorry No records found
What should I look out for while using Sodium Iodide I 131 Diagnostic?
Sodium Iodide I 131 Capsules Diagnostic is contraindicated in pregnancy [see , ].
What might happen if I take too much Sodium Iodide I 131 Diagnostic?
In the event of an overdosage of Sodium Iodide I 131 Capsules Diagnostic, monitor for thyroid suppression and consider administering a thyroid blocking agent (e.g. potassium iodide (KI) or perchlorate). Promote frequent voiding and encourage patients to maintain hydration to minimize radiation exposure.
How should I store and handle Sodium Iodide I 131 Diagnostic?
Sorry No Records found
×
Clinical Information
Chemical Structure
No Image found
Clinical Pharmacology
Iodine is actively transported by the sodium-iodide symporter (NIS) protein, in thyroid follicular cells. Iodide is concentrated in follicular cells up to 50 times higher than in the plasma. Iodide is metabolically oxidized by thyroid peroxidase to iodinium (I) which in turn iodinates tyrosine residues of thyroglobulin (tri or tetra-iodinated tyrosine). The gamma emission of Iodine I 131 is imaged or counted.
Non-Clinical Toxicology
Sodium Iodide I 131 Capsules Diagnostic is contraindicated in pregnancy [see , ].
Use of phendimetrazine tartrate is contraindicated during or within 14 days following the administration of monoamine oxidase inhibitors because of the risk of hypertensive crisis.
Concomitant use of alcohol with phendimetrazine tartrate may result in an adverse drug reaction.
Requirements may be altered
phendimetrazine tartrate may decrease the hypotensive effect of adrenergic neuron blocking drugs.
The following adverse reaction has been described elsewhere in the labeling:
The following adverse reactions have been identified during post-approval use from Sodium Iodide I 131 Capsules Diagnostic. Because these reactions are voluntarily reported from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Adverse reactions associated with the administration of Sodium Iodide I 131 Capsules Diagnostic are:
×
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Clonazepam Description
Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake.
Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula:
C15H10ClN3O3 M.W. 315.72
×
Tips
Tips
×
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib).
228 major drug interactions (854 brand and generic names)
210 moderate drug interactions (691 brand and generic names)
2 minor drug interactions (4 brand and generic names)
Show all medications in the database that may interact with Imbruvica (ibrutinib).
